YOLFTbeta
00

Guangdong Jiaying Pharmaceutical Co Ltd

002198 · SHE · Healthcare / Drug Manufacturers - General

3.14CNY-0.14 (-4.27%)

Price History

Full chart

Market Stats

Previous Close3.28
Open3.28
Day Range3.11 – 3.29
52-Week Range2.90 – 8.43
Volume4.70M
Market Cap1.82B
P/E (TTM)0.00
Forward P/E67.57
EPS-0.01
Dividend Yield0.00%
Beta-0.03
50-Day Avg3.46
200-Day Avg5.38

About

Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat ailments, colds, orthopedics, rheumatism, gynecology, hepatobiliary diseases, tonics, and gastrointestinal disorders. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablets (capsules), Xiaoyan Lidan Tablets, and Jinju Wuhua tea, etc., as well as double throat lozenges and tablets, heavy psychotherapy, Yuqiao detoxification granules, orange peel cough granules, bone-setting Qili tablets and capsules, anti-inflammatory and choleretic tablets, chrysanthemum five-flower tea granules, Zhuang Yao Jian Shen pills, Gujing Shenrong pills, Guifuli Zhongwan, and stomach pain tablets. Guangdong Jiaying Pharmaceutical Co., Ltd. was founded in 2003 and is based in Meizhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. Yong Ping You
  • Employees594
  • HeadquartersArea B , Dongsheng Industrial Park, Meizhou, China, 514071, China
  • Websitehttps://gdjyzy.com.cn

Leadership

  • Mr. Yong Ping YouGM & Director · b. 1981
  • Mr. Jun SunDeputy GM & Secretary to the Board · b. 1986

Financials

Income Statement

Currency: CNY2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue37.46M54.35M62.67M64.58M66.35M62.33M75.25M85.91M104.47M226.74M565.82M475.81M449.95M468.08M536.98M500.50M544.73M574.71M659.20M533.23M376.17M383.75M
Growth (%)-+45.08%+15.31%+3.05%+2.73%-6.05%+20.72%+14.17%+21.60%+117.04%+149.54%-15.91%-5.43%+4.03%+14.72%-6.79%+8.84%+5.50%+14.70%-19.11%-29.46%+2.02%
Cost of Revenue21.98M24.64M24.09M23.86M26.86M25.83M34.20M45.08M52.10M96.79M221.25M126.71M105.99M125.59M144.65M107.20M148.08M143.26M229.22M186.34M151.91M153.73M
Gross Profit15.48M29.71M38.58M40.72M39.48M36.50M41.04M40.83M52.37M129.95M344.57M349.10M343.97M342.49M392.34M393.31M396.65M431.45M429.98M346.90M224.25M230.02M
Gross Margin41.32%54.67%61.56%63.05%59.51%58.56%54.54%47.53%50.13%57.31%60.90%73.37%76.45%73.17%73.06%78.58%72.82%75.07%65.23%65.06%59.62%59.94%
Operating Expense12.63M14.21M15.47M17.01M26.74M22.48M18.36M21.20M62.70M-46.39M268.39M274.65M277.28M549.40M350.50M507.45M372.60M426.08M376.09M306.38M199.00M185.34M
Operating Income2.84M15.50M23.11M23.70M12.74M14.02M22.68M19.63M-10.33M176.34M76.18M74.45M66.69M-206.91M41.84M-114.15M24.05M5.38M53.88M40.52M25.26M44.68M
Operating Margin7.59%28.53%36.87%36.70%19.21%22.50%30.14%22.85%-9.89%77.77%13.46%15.65%14.82%-44.20%7.79%-22.81%4.42%0.94%8.17%7.60%6.71%11.64%
EBITDA5.36M20.07M29.24M35.64M22.90M24.25M39.02M36.97M23.29M195.74M112.97M102.00M93.89M-177.20M71.30M-83.48M55.25M35.30M77.48M63.62M44.68M59.43M
EBITDA Margin14.31%36.93%46.65%55.18%34.51%38.90%51.85%43.03%22.29%86.33%19.97%21.44%20.87%-37.86%13.28%-16.68%10.14%6.14%11.75%11.93%11.88%15.49%
Net Income2.77M15.42M22.11M24.42M13.72M15.08M25.25M20.24M7.57M139.49M73.65M66.35M55.17M-214.76M35.88M-122.18M19.84M1.48M43.93M34.32M20.61M30.48M
Net Income Margin7.39%28.37%35.28%37.81%20.68%24.19%33.55%23.56%7.24%61.52%13.02%13.95%12.26%-45.88%6.68%-24.41%3.64%0.26%6.66%6.44%5.48%7.94%
R&D-------51.35K-2.05M15.24M12.23M11.20M10.11M12.41M14.35M9.38M14.40M15.34M10.10M6.76M9.04M
R&D as % of Total Revenue-------0.06%-0.90%2.69%2.57%2.49%2.16%2.31%2.87%1.72%2.51%2.33%1.89%1.80%2.35%
Interest Expense518.24K523.06K291.76K89.60K513.97K175.87K946.88K1.61M1.45M1.53M2.61M2.53M1.55M1.90M1.90M3.52M4.04M1.08M490.92K33.60K38.97K189.40K
Interest Expense % of Total Revenue1.38%0.96%0.47%0.14%0.77%0.28%1.26%1.87%1.39%0.68%0.46%0.53%0.35%0.41%0.35%0.70%0.74%0.19%0.07%0.01%0.01%0.05%

Balance Sheet

Currency: CNY2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets71.92M91.23M120.05M245.48M235.24M253.33M300.87M306.55M314.25M919.00M1.04B1.05B1.10B876.61M889.56M855.94M808.44M807.34M846.65M847.56M838.82M849.23M
Total Liabilities22.95M26.84M37.42M32.85M8.89M11.91M42.40M36.04M36.17M109.35M171.94M118.30M114.38M126.80M104.21M192.77M125.43M122.85M118.23M84.58M80.60M131.30M
Total Equity48.97M64.39M82.63M212.62M226.35M241.42M258.47M270.51M278.08M809.66M863.35M929.70M984.87M749.81M785.35M663.17M683.01M684.48M728.42M762.98M758.22M717.93M
Cash2.40M21.52M37.52M153.56M81.87M32.90M30.33M10.53M21.60M56.34M33.29M46.22M73.33M81.97M114.95M122.31M142.24M239.38M183.86M133.51M336.14M164.65M
Total Debt-7.50M22.00M22.00M--22.50M22.50M18.55M15.00M34.00M30.10M19.90M40.00M19.00M96.78M20.16M31.11M5.77M4.37M3.33M-
Net Debt-2.40M-14.02M-15.52M-131.56M-81.87M-32.90M-7.83M11.97M-3.05M-41.34M709.81K-16.12M-53.43M-41.97M-95.95M-25.53M-122.07M-208.28M-178.08M-129.14M-336.14M-

Cash Flow

Currency: CNY2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow8.78M17.63M26.37M18.35M10.71M27.98M19.70M781.89K5.27M19.46M103.36M42.31M53.13M30.63M62.10M12.96M96.87M51.80M27.15M98.45M60.85M9.00M
Investing Cash Flow-18.04M-5.96M-12.95M-8.68M-57.91M-76.95M-35.62M-10.77M11.19M33.74M-123.25M-23.08M-14.40M-20.21M-6.79M-105.12M-18.19M55.21M-51.03M-150.24M167.18M-
Financing Cash Flow6.85M7.46M2.57M106.37M-24.49M-13.35M-9.81M-5.40M-19.60M-10.50M2.17M-11.61M-1.79M-22.33M99.51M-83.80M15.09M-31.56M-445-25.40M-
Capital Expenditure18.04M6.09M12.95M8.68M29.05M76.95M35.62M10.77M6.58M8.72M98.74M33.42M11.98M18.44M8.95M18.82M11.68M2.34M2.74M5.06M38.70M109.92M
Free Cash Flow-9.26M11.54M13.42M9.67M-18.34M-48.97M-15.93M-9.99M-1.30M10.74M4.62M8.89M41.15M12.19M53.15M-5.85M85.19M49.46M24.41M93.39M22.14M-100.92M
Dividends Paid-43.50K5.07M1.41M513.97K-9.15M9.81M1.45M7.62M22.16M2.41M1.41M21.89M1.33M3.45M3.80M1.02M454.17K44525.40M-
FCF to OCF-105.37%65.45%50.89%52.72%-171.19%-175.00%-80.87%-1277.92%-24.73%55.21%4.47%21.02%77.45%39.81%85.59%-45.16%87.94%95.48%89.91%94.86%36.39%-1121.08%
Dividend Paid to FCF-0.38%37.82%14.53%-2.80%--57.43%-98.15%-111.17%70.91%479.62%27.08%3.41%179.50%2.51%-58.96%4.45%2.06%1.86%0.00%114.71%-

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Oct 20, 2016Mar 1, 2017Apr 26, 2017Aug 14, 2017Oct 26, 2017Dec 31, 2017Apr 26, 2018Aug 17, 2018Oct 22, 2018Dec 31, 2018Apr 24, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 25, 2020Aug 31, 2020Oct 24, 2020Dec 31, 2020Apr 28, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Dec 29, 2023Dec 31, 2023May 23, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 23, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------------------
EPS Actual0.010.010.010.010.010.010.010.030.020.000.000.03-0.01-0.000.010.020.010.010.020.290.030.030.040.050.030.040.020.050.020.020.010.070.020.000.01-0.450.020.010.010.040.020.010.01-0.280.00-0.010.010.040.02-0.010.00-0.010.010.010.030.040.020.010.010.020.010.00-0.010.040.030.010.000.020.03-0.05
Surprise----------------------------------------------------------------------
Timing------------------------------Pre-marketPre-marketPre-marketPre-marketAfter-hours-Pre-marketAfter-hoursPre-market-Pre-market-----------------After-hours-After-hours---After-hours-----

Key Statistics & Ratios

Market Cap1.82B
Enterprise Value1.73B
Trailing P/E0.00
Forward P/E67.57
PEG Ratio1.24
Price / Sales5.18
Price / Book2.61
EPS-0.01
Book Value1.87
Revenue (TTM)350.56M
Gross Profit (TTM)189.89M
EBITDA28.44M
Profit Margin-0.74%
Operating Margin-47.57%
Return on Equity-0.36%
Return on Assets0.83%
Shares Outstanding507.51M
Shares Float301.13M
Beta-0.03
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
0.05Jun 21, 2024
20171×
0.04Oct 9, 2017
20141×
0.04Apr 3, 2014
20131×
0.01May 8, 2013
20111×
0.02Apr 18, 2011
20101×
0.01Sep 8, 2010

Stock Splits

  • Apr 3, 201420:10
  • Apr 18, 201112.5:10
  • Sep 8, 20102:1